Autophagy study in children with Crohn’s disease
Treatments studied
Part of Digestive system clinical trials.
This trial studies “autophagy,” a normal body process, to better understand and possibly improve care for children with Crohn’s disease. Children will need a scope exam and may get assigned to a Crohn’s group or a non-Crohn’s group for comparison.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 6 and 17 years old
- Weigh more than 25 kg at enrollment
- If in the Crohn’s group: have Crohn’s disease and need an ileocolonoscopy (scope) now for diagnosis or follow-up
- If in the control group: do not have Crohn’s disease but still need an ileoendoscopy/scope evaluation
- Be able to give consent (child or parent/guardian) and have health coverage like social security
- Not have major exclusions, such as an active infection, ongoing antibiotics, refusal to join, being in another competing drug study, or being pregnant/breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children newly diagnosed with Crohn’s disease to see how results from scans and endoscopy (camera scope) relate to outcomes over the first year. It may help doctors choose better early treatment plans and monitor children more effectively.
This study tests a modified version of the Crohn's Disease Exclusion Diet (CDED) that uses Nordic foods to see if it works as well as the standard CDED diet in children with mild-to-moderate Crohn's disease. It looks for ways to reduce inflammation without using steroids.
This study looks at proteins from your body and gut bacteria to understand Crohn's disease better. You may join if you are about to have your first colonoscopy for suspected Crohn's and have not had any treatment yet.
This study looks at outcomes after children with Crohn’s disease have part of the bowel removed (ileo-cecal resection). It may help doctors improve post-surgery care, especially for preventing flare-ups in the months after surgery.
This trial collects information from children who are newly diagnosed with inflammatory bowel disease (IBD) and follows them to understand safety in real life. It may help doctors improve early diagnosis and treatment planning for kids with IBD.
This trial studies a combination of immune-suppressing treatments for children with Crohn’s disease that is not well controlled. It may help reduce inflammation and improve symptoms if you meet the study’s disease-activity and safety requirements.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.